Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shoichi Hazama

Showing results (1-10 of 197) with videos related to

Pageof 20
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 19, 2008
[CPT-11 (Irinotecan)]Shoichi Hazama, Masaaki Oka
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 25, 2012
[Epitope peptide vaccine with oncoantigen for cancer and its biomarker]Shoichi Hazama, Kazunari Maeda, Masaaki Oka
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 19, 2019
[Cancer Vaccine Focused on Neoantigens]Yoshitaro Shindo, Shoichi Hazama, Hiroaki Nagano
Expert Review of Anticancer Therapy|October 9, 2018
Combination treatment of advanced pancreatic cancer using novel vaccine and traditional therapiesHiroto Matsui, Shoichi Hazama, Yoshitaro Shindo, et al.
Annals of Gastroenterological Surgery|July 14, 2018
Current status of immunotherapy against gastrointestinal cancers and its biomarkers: Perspective for precision immunotherapyShoichi Hazama, Koji Tamada, Yoshiyuki Yamaguchi, et al.
Anticancer Research|May 16, 2009
Increased prevalence of regulatory T-cells in the peripheral blood of patients with gastrointestinal cancerKazuhisa Tokuno, Shoichi Hazama, Shigefumi Yoshino, et al.
Cancer Science|May 6, 2017
Rapid and sensitive detection of UGT1A1 polymorphisms associated with irinotecan toxicity by a novel DNA microarrayRyouichi Tsunedomi, Shoichi Hazama, Naoko Okayama, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 19, 2003
[Clinical evaluation of intrapleural or peritoneal administration of lentinan and OK-432 for malignant effusion]Toru Kawaoka, Shigefumi Yoshino, Shoichi Hazama, et al.
Cancers|August 25, 2019
Novel Biomarkers for Personalized Cancer ImmunotherapyYoshitaro Shindo, Shoichi Hazama, Ryouichi Tsunedomi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 29, 2011
[A case of gastrointestinal stromal tumor (GIST) successfully treated with resection after a long-term control medication by molecular targeted drugs]Yuka Inoue, Shigefumi Yoshino, Nobuaki Suzuki, et al.
Pageof 20

Showing results (1-10 of 197) with videos related to

Sort By:
Pageof 20
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 19, 2008
[CPT-11 (Irinotecan)]Shoichi Hazama, Masaaki Oka
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 25, 2012
[Epitope peptide vaccine with oncoantigen for cancer and its biomarker]Shoichi Hazama, Kazunari Maeda, Masaaki Oka
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 19, 2019
[Cancer Vaccine Focused on Neoantigens]Yoshitaro Shindo, Shoichi Hazama, Hiroaki Nagano
Expert Review of Anticancer Therapy|October 9, 2018
Combination treatment of advanced pancreatic cancer using novel vaccine and traditional therapiesHiroto Matsui, Shoichi Hazama, Yoshitaro Shindo, et al.
Annals of Gastroenterological Surgery|July 14, 2018
Current status of immunotherapy against gastrointestinal cancers and its biomarkers: Perspective for precision immunotherapyShoichi Hazama, Koji Tamada, Yoshiyuki Yamaguchi, et al.
Anticancer Research|May 16, 2009
Increased prevalence of regulatory T-cells in the peripheral blood of patients with gastrointestinal cancerKazuhisa Tokuno, Shoichi Hazama, Shigefumi Yoshino, et al.
Cancer Science|May 6, 2017
Rapid and sensitive detection of UGT1A1 polymorphisms associated with irinotecan toxicity by a novel DNA microarrayRyouichi Tsunedomi, Shoichi Hazama, Naoko Okayama, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 19, 2003
[Clinical evaluation of intrapleural or peritoneal administration of lentinan and OK-432 for malignant effusion]Toru Kawaoka, Shigefumi Yoshino, Shoichi Hazama, et al.
Cancers|August 25, 2019
Novel Biomarkers for Personalized Cancer ImmunotherapyYoshitaro Shindo, Shoichi Hazama, Ryouichi Tsunedomi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 29, 2011
[A case of gastrointestinal stromal tumor (GIST) successfully treated with resection after a long-term control medication by molecular targeted drugs]Yuka Inoue, Shigefumi Yoshino, Nobuaki Suzuki, et al.
Pageof 20